Advertisement

Topics

NICE recommends funding for psoriasis and type 1 diabetes drugs

08:34 EDT 12 Jul 2019 | pharmaphorum

Patients in England and Wales should soon be able to access AbbVie’s psoriasis drug Skyrizi after NICE recommended regular NHS funding. In final draft guidance the cost-effectiveness body okayed funding in adults who have failed conventional syste...

Original Article: NICE recommends funding for psoriasis and type 1 diabetes drugs

NEXT ARTICLE

More From BioPortfolio on "NICE recommends funding for psoriasis and type 1 diabetes drugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Alzumab (Itolizumab)
Biocon Launches ALZUMAb™ - a ‘First in Class’ Novel Biologic Treatment for Psoriasis Patients in India • ALZUMAb™-World's first novel anti-CD6 antibody developed by Biocon to address a large unmet need for th...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...